[1] Puppo F, Scudeletti M, Indiveri F, et al. Serum HLA class Ⅰ antigens:markers and modulators of an immune response? Immunol Today, 1995,16:124-127.
[2] Tsuchiya N, Shiota M, Yamaguchi A, et al. Elevated serum level of soluble HLA class Ⅰ antigens in patients with systemic lupus erythematosus. Arthritis Rheum,1996,39:792-796.
[3] Wolf RE, Adamashvili IM, Gelder FB, et al. Soluble HLA-Ⅰ in rheumatic diseases. Hum Immunol, 1998,59:644-649.
[4] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studied in SLE. Arthritis Rheum, 1992,35:630-640.
[5] 兰炯采, 石宁, 杨崇礼, 等.可溶性人类白细胞抗原Ⅰ的测定及其对器官移植排斥反应的监控.中华医学检验杂志, 1999,22:33-35.
[6] Brieva JA, Villar LM, Leoro G, et al. Soluble HLA class Ⅰ antigen secretion by normal lymphocytes:relationship with cell activation and effect of interferon gamma. Clin Exp Immunol, 1990,82:390-395. |
